Leptin is overexpressed in the tumor microenvironment of obese patients with estrogen receptor positive breast cancer

Hosney,Mohamed; Sabet,Salwa; El‑Shinawi,Mohamed; Gaafar,Khadiga M.; Mohamed,Mona M.

doi:10.3892/etm.2017.4291

Leptin is overexpressed in the tumor microenvironment of obese patients with estrogen receptor positive breast cancer

Authors:
- Mohamed Hosney
- Salwa Sabet
- Mohamed El‑Shinawi
- Khadiga M. Gaafar
- Mona M. Mohamed
View Affiliations

Affiliations: Department of Zoology, Cancer Biology Research Laboratory (CBRL), Faculty of Science, Cairo University, Giza 12613, Egypt, Department of General Surgery, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt
Published online on: March 30, 2017 https://doi.org/10.3892/etm.2017.4291
Pages: 2235-2246
Copyright: © Hosney et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the potential role of leptin in the progression of breast cancer and the associated cell proliferation signalling pathway(s). A total of 44 female patients diagnosed with breast cancer and 24 healthy donors from Ain Shams University Hospitals (Cairo, Egypt) were enrolled in the present study. The present study assessed leptin expression in breast cancer tissues at the gene and protein level using reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and immunohistochemistry. The results demonstrate that the expression of leptin was significantly higher in tissue of breast cancer samples from obese patients than overweight and control samples (P<0.001). ELISA results indicated a significant increase (P<0.001) of leptin expression in obese patients. To investigate whether there is any difference in leptin expression between the peripheral and tumor microenvironment blood of patients with breast cancer, the concentration of leptin was assessed in plasma from both using ELISA assays. The results demonstrated a statistically significant increase in the level of leptin in plasma samples from the tumor microenvironment of obese patients with estrogen receptor positive (ER+) breast cancer, compared with peripheral plasma samples. Furthermore, the leptin gene was overexpressed in obese ER+ breast cancer tissue. RT‑qPCR was also performed to assess the expression of genes involved in proliferation pathways including leptin receptor (LEPR), aromatase, mitogen activated protein kinase (MAPK) and signal transducer and activator of transcription‑3 (STAT3). A positive association between leptin expression, LEPR, aromatase, MAPK and STAT3 was detected in tissue samples of patients with breast cancer. The current study concluded that leptin may enhance breast cancer progression by inducing the expression of JAK/STAT3, ERK1/2 and estrogen pathways in obese patients breast cancer.

View Figures

View References

1	Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI
2	Bray F, Ren JS, Masuyer E and Ferlay J: Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 132:1133–1145. 2013. View Article : Google Scholar : PubMed/NCBI
3	Ibrahim AS, Khaled HM, Mikhail NN, Baraka H and Kamel H: Cancer incidence in egypt: Results of the national population-based cancer registry program. J Cancer Epidemiol. 2014:4379712014. View Article : Google Scholar : PubMed/NCBI
4	Newell B, Proust K, Dyball R and McManus P: Seeing obesity as a systems problem. N S W Public Health Bull. 18:214–218. 2007. View Article : Google Scholar : PubMed/NCBI
5	Kaur T and Zhang ZF: Obesity, breast cancer and the role of adipocytokines. Asian Pac J Cancer Prev. 6:547–552. 2005.PubMed/NCBI
6	Popkin BM: Understanding global nutrition dynamics as a step towards controlling cancer incidence. Nat Rev Cancer. 7:61–67. 2007. View Article : Google Scholar : PubMed/NCBI
7	Reeves GK, Pirie K, Beral V, Green J, Spencer E and Bull D; Million Women Study Collaboration, : Cancer incidence and mortality in relation to body mass index in the Million Women Study: Cohort study. BMJ. 335:11342007. View Article : Google Scholar : PubMed/NCBI
8	Danaei G, Hoorn S Vander, Lopez AD, Murray CJ and Ezzati M; Comparative Risk Assessment collaborating group (Cancers), : Causes of cancer in the world: Comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 366:1784–1793. 2005. View Article : Google Scholar : PubMed/NCBI
9	Frühbeck G, Gómez-Ambrosi J, Muruzábal FJ and Burrell MA: The adipocyte: A model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab. 280:E827–E847. 2001.PubMed/NCBI
10	Porter GA, Inglis KM, Wood LA and Veugelers PJ: Effect of obesity on presentation of breast cancer. Ann Surg Oncol. 13:327–332. 2006. View Article : Google Scholar : PubMed/NCBI
11	Huber KE, Carey LA and Wazer DE: Breast cancer molecular subtypes in patients with locally advanced disease: Impact on prognosis, patterns of recurrence, and response to therapy. Semin Radiat Oncol. 19:204–210. 2009. View Article : Google Scholar : PubMed/NCBI
12	Diamond T, Vine J, Smart R and Butler P: Thyrotoxic bone disease in women: A potentially reversible disorder. Ann Intern Med. 120:8–11. 1994. View Article : Google Scholar : PubMed/NCBI
13	Zhang Y, Proenca R, Maffei M, Barone M, Leopold L and Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI
14	Tartaglia LA: The leptin receptor. J Biol Chem. 272:6093–6096. 1997. View Article : Google Scholar : PubMed/NCBI
15	Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK and Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269:543–546. 1995. View Article : Google Scholar : PubMed/NCBI
16	Bray GA: The underlying basis for obesity: Relationship to cancer. J Nutr. 132(11 Suppl): S3451–S3455. 2002.
17	Andò S and Catalano S: The multifactorial role of leptin in driving the breast cancer microenvironment. Nat Rev Endocrinol. 8:263–275. 2011. View Article : Google Scholar : PubMed/NCBI
18	Ahima RS and Flier JS: Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 11:327–332. 2000. View Article : Google Scholar : PubMed/NCBI
19	Bonnet M, Delavaud C, Laud K, Gourdou I, Leroux C, Djiane J and Chilliard Y: Mammary leptin synthesis, milk leptin and their putative physiological roles. Reprod Nutr Dev. 42:399–413. 2002. View Article : Google Scholar : PubMed/NCBI
20	Snoussi K, Strosberg AD, Bouaouina N, Ben Ahmed S, Helal AN and Chouchane L: Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer. 6:382006. View Article : Google Scholar : PubMed/NCBI
21	Garofalo C and Surmacz E: Leptin and cancer. J Cell Physiol. 207:12–22. 2006. View Article : Google Scholar : PubMed/NCBI
22	Purohit A, Newman SP and Reed MJ: The role of cytokines in regulating estrogen synthesis: Implications for the etiology of breast cancer. Breast Cancer Res. 4:65–69. 2002. View Article : Google Scholar : PubMed/NCBI
23	Vona-Davis L and Rose DP: Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer. 14:189–206. 2007. View Article : Google Scholar : PubMed/NCBI
24	Mauro L, Catalano S, Bossi G, Pellegrino M, Barone I, Morales S, Giordano C, Bartella V, Casaburi I and Andò S: Evidences that leptin Up-regulates E-cadherin expression in breast cancer: Effects on tumor growth and progression. Cancer Res. 67:3412–3421. 2007. View Article : Google Scholar : PubMed/NCBI
25	Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY, Park BE, Jang Y, Cho SY and Kim HS: Potential role of leptin in angiogenesis: Leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med. 33:95–102. 2001. View Article : Google Scholar : PubMed/NCBI
26	Frankenberry KA, Skinner H, Somasundar P, McFadden DW and Vona-Davis LC: Leptin receptor expression and cell signaling in breast cancer. Int J Oncol. 28:985–993. 2006.PubMed/NCBI
27	Gonzalez RR, Cherfils S, Escobar M, Yoo JH, Carino C, Styer AK, Sullivan BT, Sakamoto H, Olawaiye A, Serikawa T, et al: Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J Biol Chem. 281:26320–26328. 2006. View Article : Google Scholar : PubMed/NCBI
28	Gonzalez R Rene, Watters A, Xu Y, Singh UP, Mann DR, Rueda BR and Penichet ML: Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer. Breast Cancer Res. 11:R362009. View Article : Google Scholar : PubMed/NCBI
29	Perera CN, Chin HG, Duru N and Camarillo IG: Leptin-regulated gene expression in MCF-7 breast cancer cells: Mechanistic insights into leptin-regulated mammary tumor growth and progression. J Endocrinol. 199:221–233. 2008. View Article : Google Scholar : PubMed/NCBI
30	El-Shinawi M, Abdelwahab SF, Sobhy M, Nouh MA, Sloane BF and Mohamed MM: Capturing and characterizing immune cells from breast tumor microenvironment: An innovative surgical approach. Ann Surg Oncol. 17:2677–2684. 2010. View Article : Google Scholar : PubMed/NCBI
31	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
32	Hwang CS, Loftus TM, Mandrup S and Lane MD: Adipocyte differentiation and leptin expression. Annu Rev Cell Dev Biol. 13:231–259. 1997. View Article : Google Scholar : PubMed/NCBI
33	Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J, Russo A, Sulkowski S and Surmacz E: Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: Possible role of obesity-related stimuli. Clin Cancer Res. 12:1447–1453. 2006. View Article : Google Scholar : PubMed/NCBI
34	Nyante SJ, Gammon MD, Kaufman JS, Bensen JT, Lin DY, Barnholtz-Sloan JS, Hu Y, He Q, Luo J and Millikan RC: Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes. Breast Cancer Res Treat. 129:593–606. 2011. View Article : Google Scholar : PubMed/NCBI
35	Jeong YJ, Bong JG, Park SH, Choi JH and Oh HK: Expression of leptin, leptin receptor, adiponectin, and adiponectin receptor in ductal carcinoma in situ and invasive breast cancer. J Breast Cancer. 14:96–103. 2011. View Article : Google Scholar : PubMed/NCBI
36	Stattin P, Söderberg S, Biessy C, Lenner P, Hallmans G, Kaaks R and Olsson T: Plasma leptin and breast cancer risk: A prospective study in northern Sweden. Breast Cancer Res Treat. 86:191–196. 2004. View Article : Google Scholar : PubMed/NCBI
37	Miyoshi Y, Funahashi T, Tanaka S, Taguchi T, Tamaki Y, Shimomura I and Noguchi S: High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer. 118:1414–1419. 2006. View Article : Google Scholar : PubMed/NCBI
38	Harris HR, Tworoger SS, Hankinson SE, Rosner BA and Michels KB: Plasma leptin levels and risk of breast cancer in premenopausal women. Cancer Prev Res (Phila). 4:1449–1456. 2011. View Article : Google Scholar : PubMed/NCBI
39	Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA and Marchbanks PA: Body mass and mortality after breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev. 14:2009–2014. 2005. View Article : Google Scholar : PubMed/NCBI
40	Grossmann ME, Ray A, Nkhata KJ, Malakhov DA, Rogozina OP, Dogan S and Cleary MP: Obesity and breast cancer: Status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev. 29:641–653. 2010. View Article : Google Scholar : PubMed/NCBI
41	Razmkhah M, Jaberipour M, Hosseini A, Safaei A, Khalatbari B and Ghaderi A: Expression profile of IL-8 and growth factors in breast cancer cells and adipose-derived stem cells (ASCs) isolated from breast carcinoma. Cell Immunol. 265:80–85. 2010. View Article : Google Scholar : PubMed/NCBI
42	Lim S, Honek J, Xue Y, Seki T, Cao Z, Andersson P, Yang X, Hosaka K and Cao Y: Cold-induced activation of brown adipose tissue and adipose angiogenesis in mice. Nat Protoc. 7:606–615. 2012. View Article : Google Scholar : PubMed/NCBI
43	Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, et al: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 257:79–83. 1999. View Article : Google Scholar : PubMed/NCBI
44	Tessitore L, Vizio B, Jenkins O, de Stefano I, Ritossa C, Argiles JM, Benedetto C and Mussa A: Leptin expression in colorectal and breast cancer patients. Int J Mol Med. 5:421–426. 2000.PubMed/NCBI
45	Ostlund RE Jr..Yang JW, Klein S and Gingerich R: Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab. 81:3909–3913. 1996. View Article : Google Scholar : PubMed/NCBI
46	Hou WK, Xu YX, Yu T, Zhang L, Zhang WW, Fu CL, Sun Y, Wu Q and Chen L: Adipocytokines and breast cancer risk. Chin Med J (Engl). 120:1592–1596. 2007.PubMed/NCBI
47	Al Awadhi SA, Al Khaldi RM, Al Rammah T, Kapila K and Mojiminiyi OA: Associations of adipokines & insulin resistance with sex steroids in patients with breast cancer. Indian J Med Res. 135:500–505. 2012.PubMed/NCBI
48	Mohammadzadeh G, Ghaffari MA, Bafandeh A and Hosseini SM: Association of serum soluble leptin receptor and leptin levels with breast cancer. J Res Med Sci. 19:433–438. 2014.PubMed/NCBI
49	Lorincz AM and Sukumar S: Molecular links between obesity and breast cancer. Endocr Relat Cancer. 13:279–292. 2006. View Article : Google Scholar : PubMed/NCBI
50	Strong AL, Ohlstein JF, Biagas BA, Rhodes LV, Pei DT, Tucker HA, Llamas C, Bowles AC, Dutreil MF, Zhang S, et al: Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers. Breast Cancer Res. 17:1122015. View Article : Google Scholar : PubMed/NCBI
51	Zhang Y, Daquinag A, Traktuev DO, Amaya-Manzanares F, Simmons PJ, March KL, Pasqualini R, Arap W and Kolonin MG: White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res. 69:5259–5266. 2009. View Article : Google Scholar : PubMed/NCBI
52	Leek RD: The prognostic role of angiogenesis in breast cancer. Anticancer Res. 21:4325–4331. 2001.PubMed/NCBI
53	Somiari SB, Shriver CD, Heckman C, Olsen C, Hu H, Jordan R, Arciero C, Russell S, Garguilo G, Hooke J and Somiari RI: Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer. Cancer Lett. 233:98–107. 2006. View Article : Google Scholar : PubMed/NCBI
54	Linderholm BK, Hellborg H, Johansson U, Elmberger G, Skoog L, Lehtiö J and Lewensohn R: Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer. Ann Oncol. 20:1639–1646. 2009. View Article : Google Scholar : PubMed/NCBI
55	Strong AL, Strong TA, Rhodes LV, Semon JA, Zhang X, Shi Z, Zhang S, Gimble JM, Burow ME and Bunnell BA: Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways. Breast Cancer Res. 15:R1022013. View Article : Google Scholar : PubMed/NCBI
56	Nieman KM, Romero IL, Van Houten B and Lengyel E: Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta. 1831:1533–1541. 2013. View Article : Google Scholar : PubMed/NCBI
57	Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL and Ferrante AW Jr.: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 112:1796–1808. 2003. View Article : Google Scholar : PubMed/NCBI
58	Gnerlich JL, Yao KA, Fitchev PS, Goldschmidt RA, Bond MC, Cornwell M and Crawford SE: Peritumoral expression of adipokines and fatty acids in breast cancer. Ann Surg Oncol. 20 Suppl 3:S731–S738. 2013. View Article : Google Scholar : PubMed/NCBI
59	Dehdashti F, Mortimer JE, Trinkaus K, Naughton MJ, Ellis M, Katzenellenbogen JA, Welch MJ and Siegel BA: PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer. Breast Cancer Res Treat. 113:509–517. 2009. View Article : Google Scholar : PubMed/NCBI
60	Calle EE, Rodriguez C, Walker-Thurmond K and Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 348:1625–1638. 2003. View Article : Google Scholar : PubMed/NCBI
61	Catalano S, Marsico S, Giordano C, Mauro L, Rizza P, Panno ML and Andò S: Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. J Biol Chem. 278:28668–28676. 2003. View Article : Google Scholar : PubMed/NCBI
62	Garofalo C, Sisci D and Surmacz E: Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells. Clin Cancer Res. 10:6466–6475. 2004. View Article : Google Scholar : PubMed/NCBI
63	Dubois V, Jardé T, Delort L, Billard H, Bernard-Gallon D, Berger E, Geloen A, Vasson MP and Caldefie-Chezet F: Leptin induces a proliferative response in breast cancer cells but not in normal breast cells. Nutr Cancer. 66:645–655. 2014. View Article : Google Scholar : PubMed/NCBI
64	Khanal T, Kim HG, Do MT, Choi JH, Won SS, Kang W, Chung YC, Jeong TC and Jeong HG: Leptin induces CYP1B1 expression in MCF-7 cells through ligand-independent activation of the ERα pathway. Toxicol Appl Pharmacol. 277:39–48. 2014. View Article : Google Scholar : PubMed/NCBI
65	Alshaker H, Krell J, Frampton AE, Waxman J, Blyuss O, Zaikin A, Winkler M, Stebbing J, Yagüe E and Pchejetski D: Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway. Breast Cancer Res. 16:4262014. View Article : Google Scholar : PubMed/NCBI
66	Qian Y, Shi D, Qiu J, Zhu F, Qian J, He S, Shu Y, Yin Y and Chen X: ObRb downregulation increases breast cancer cell sensitivity to tamoxifen. Tumour Biol. 36:6813–6821. 2015. View Article : Google Scholar : PubMed/NCBI
67	Wang L, Tang C, Cao H, Li K, Pang X, Zhong L, Dang W, Tang H, Huang Y, Wei L, et al: Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells. Cancer Biol Ther. 16:1220–1230. 2015. View Article : Google Scholar : PubMed/NCBI
68	Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T and Akira S: Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA. 94:3801–3804. 1997. View Article : Google Scholar : PubMed/NCBI
69	Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell JE Jr.: Stat3 as an oncogene. Cell. 98:295–303. 1999. View Article : Google Scholar : PubMed/NCBI
70	Giordano C, Chemi F, Panza S, Barone I, Bonofiglio D, Lanzino M, Cordella A, Campana A, Hashim A, Rizza P, et al: Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity. Oncotarget. 7:1262–1275. 2015.